artemisinin
Commercial- Indications
- Parasitic infections
Company intelligence / Profile preview
Holley Pharmaceuticals is one of the world’s largest manufacturers and suppliers of pharmaceutical-grade artemisinin and its derivatives, which are key components in antimalarial therapies. The company is recognized for its high-quality production standards, including cGMP compliance and FDA regulations adherence. Its main product line includes artemisinin-based combination therapies such as dihydroartemisinin-piperaquine, recommended by the WHO for malaria treatment[1][3].
5 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Holley Pharmaceuticals.